Most business owners entering a sale process have no idea how long the journey actually takes — and that gap between expectation and reality can cause costly mistakes on both sides of the table. This episode of HoldCo draws on this in-depth look at M&A deal timelines to give buyers and sellers a grounded, stage-by-stage picture of how transactions unfold in practice — without the sugarcoating.

From the first exploratory conversation to closing day, the episode walks through each phase of a deal and what drives the clock forward or backward at every step:

• Early-stage exploration — Why the initial "feeling out" period is the most underestimated phase, and how long it can realistically stretch before formal talks begin.
• Preparation and groundwork — What sellers and buyers each need to do before the process gets serious, and why a few weeks of upfront organization can save months downstream.
• The courtship and LOI stage — How NDAs, controlled information sharing, and competing offers shape the timeline before a Letter of Intent is ever signed — and what an exclusivity clause really means for both sides.
• Due diligence — Why seller readiness is the single biggest variable in this phase, and how disorganized records or a surprise liability can stall an otherwise healthy deal.
• Legal documentation, financing, and regulatory review — The three parallel workstreams that often cause the most unexpected delays, especially in larger or cross-border transactions.
• Why rushing almost always backfires — The counterintuitive case for a measured pace, and how deliberate deal-making actually improves the odds of reaching closing without last-minute renegotiations.

The episode lands on a clear benchmark — most transactions run somewhere between six months and a year from initial interest to close — while making the case that knowing the variables in advance is far more valuable than chasing an arbitrary deadline. For more from the show, check out Why Your Business Is Not Worth a Premium: The SBA Loan Reality Check, which digs into how buyers are actually financing acquisitions and what that means for seller expectations on valuation.

Mergers & Acquisitions

Selling a business is one of the biggest financial events of a founder's life, yet many sellers walk into the process with a valuation in mind that a lender will never support. This episode of HoldCo unpacks the mechanics behind that gap, drawing on the SBA loan reality check behind business valuation — a detailed look at why the number in a seller's head and the number an underwriter approves are so often worlds apart.

The episode works through the key concepts and practical constraints that shape what a buyer can actually pay when SBA financing is involved:

• How SBA 7(a) loans set the rules: Competitive rates and long terms make these loans attractive, but the requirement that business cash flow cover debt service is the constraint that quietly kills deals.
• Debt Service Coverage (DSC) explained: The SBA's 1.5x minimum ratio — and the 1.7x threshold most lenders prefer — determines the maximum supportable purchase price, not seller sentiment or sweat equity.
• Why EBITDA can mislead: Underwriters underwrite free cash flow, not EBITDA. When non-cash add-backs like depreciation and amortization are doing heavy lifting in the income statement, stripping them out can significantly reduce what the lender will support.
• The levers that push value down: Rising interest rates, seasonal working capital needs, aggressive personal add-backs, and the size and cost of any seller note all tighten the DSC ratio and compress the supportable price.
• Why synergies don't rescue premiums: Strategic buyers and PE groups may see upside, but lenders underwrite today's cash flow — any premium above the debt ceiling has to come out of the buyer's equity, which most sophisticated acquirers won't do if it hurts their return math.
• What sellers can actually control: Running a competitive process, understanding the buyer's equity capacity, and modeling DSC across interest rate scenarios before going to market are the most reliable ways to maximize outcome.

The core message is straightforward but uncomfortable: the market for small businesses is more rational and more constrained than most owners want to believe. A premium is possible, but only if a buyer is willing to commit meaningful additional equity — and earning that commitment requires the right process, the right buyer, and realistic expectations going in. For more from the show, listen to How Bankers Make Bad Deals Look Accretive (And How to See Through It).

Hold

Accretion/dilution analysis is the single most-cited metric in merger presentations — and arguably the most misused. This episode of HoldCo digs into the mechanics and manipulation of EPS accretion math in M&A deals, unpacking why a number that looks clean and decisive can be quietly engineered to make a weak deal look like a strong one. Whether you're sitting across from a sell-side pitch or evaluating your own capital allocation, understanding what EPS accretion doesn't measure is just as important as understanding what it does.

The episode walks through the architecture of a standard accretion model — and the specific levers that, when stacked together, can transform an ordinary combination into a slide that smiles. Key topics include:

• What accretion/dilution actually measures — and why a one-period EPS snapshot tells you nothing about whether value was created or destroyed.
• Purchase price and growth assumptions — how a full entry price gets buried beneath generous margin expansion projections that make the headline math hold together.
• Synergy modeling — why cost synergies are treated as frictionless, revenue synergies quietly inflate the earnings estimate, and integration costs vanish into the footnotes as "non-recurring."
• Financing mix and share count timing — how cheap leverage delivers a mechanical EPS boost, and how weighted-average share timing assumptions can airbush the per-share result without technically lying.
• Adjusted EPS and amortization add-backs — when the bridge between adjusted and GAAP figures is wide and indefinite, you're being asked to ignore recurring economic costs dressed up as one-time noise.
• What disciplined acquirers look at instead — operating cash flow after capital needs, real integration outlays, cost-of-capital hurdles, and stress tests that model synergies coming in at a fraction of the projection.

The core argument: EPS accretion isn't dishonest by nature — it's incomplete by design. A deal can be accretive and still leave shareholders poorer. The antidote is following the cash, pricing the risk, and insisting on assumptions that reflect how money actually moves rather than how the model needs it to move. The episode also flags the language patterns — "run-rate," "normalized," "accretive on an adjusted basis" — that tend to cluster around deals that need more help than they let on. For more on deal mechanics and valuation, you might also enjoy Your Startup's Valuation Is a Lie — And That's Exactly the Point, which takes a similarly clear-eyed look at how numbers get shaped for the room.

Mergers & Acquisitions